Related Experiment Videos
Bioassay of 1-phenyl-3-methyl-5-pyrazolone for possible carcinogenicity
Abstract:
A bioassay of 1-phenyl-3-methyl-5-pyrazolone for possible carcinogenicity was conducted using Fischer 344 rats and B6C3F1 mice. 1-Phenyl-3-methyl-5-pyrazolone was administered in the feed, at either of two concentrations, to groups of 49 or 50 male and 50 female animals of each species. The high and low concentrations of 1-phenyl-3-methyl-5-pyrazolone utilized were, respectively, 5,000 and 2,500 ppm for rats and 15,000 and 7,500 ppm for mice. Twenty animals of each species and sex were placed on test as controls. After a 103-week period of chemical administration, there was an additional observation period of 2 weeks for rats. A 102-week period of chemical administration was followed by an additional 2-week observation period for mice. In both species adequate numbers of animals survived sufficiently long to be at risk from late-developing tumors. Compound-related mean body weight depression was observed in mice, but not in rats. In addition, no significant accelerated mortality or other signs of toxicity were associated with the dietary administration of 1-phenyl-3-methyl-5-pyrazolone to rats; therefore, it is possible that the compound was not administered to rats at the maximum tolerated concentration. There were no tumors in either sex of rats or mice for which a significant positive association could be established between chemical administration and incidence. Under the conditions of this bioassay, there was no evidence for the carcinogenicity of 1-phenyl-3-methyl-5-pyrazolone to Fischer 344 rats or B6C3F1 mice.
Insights
This study found no evidence that 1-phenyl-3-methyl-5-pyrazolone causes cancer in Fischer 344 rats or B6C3F1 mice. Long-term bioassays in both species showed no significant tumor development linked to the chemical.
Area of Science:
- Toxicology
- Carcinogenesis Research
- Animal Models
Background:
- 1-Phenyl-3-methyl-5-pyrazolone is a chemical compound requiring evaluation for potential health risks.
- Assessing carcinogenicity is crucial for understanding chemical safety in biological systems.
Purpose of the Study:
- To determine if 1-phenyl-3-methyl-5-pyrazolone exhibits carcinogenic potential in rodent models.
- To evaluate the long-term effects of dietary exposure to this compound.
Main Methods:
- Fischer 344 rats and B6C3F1 mice were administered 1-phenyl-3-methyl-5-pyrazolone orally via feed at varying concentrations for over 100 weeks.
- Control groups received no chemical exposure.
- Survival rates and tumor incidence were monitored throughout the study period.
Main Results:
- No significant increase in tumor incidence was observed in either male or female rats or mice exposed to 1-phenyl-3-methyl-5-pyrazolone.
- Mice experienced compound-related mean body weight depression, but rats did not show significant toxicity or mortality.
- Adequate survival in both species allowed for the assessment of late-developing tumors.
Conclusions:
- Under the conditions of this bioassay, 1-phenyl-3-methyl-5-pyrazolone did not demonstrate evidence of carcinogenicity in Fischer 344 rats or B6C3F1 mice.
- Further investigation may be warranted regarding the maximum tolerated dose in rats, as toxicity was not observed.